● Recruiting

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Condition: Neovascular Age-related Macular Degeneration · Sponsor: Genentech, Inc.

PhasePhase 4

Planned participants188

Who can joinAll sexes, 50 Years to no upper limit

Healthy volunteersNo

About this study

This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W).

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: ML43000 https://forpatients.roche.com/ · 888-662-6728 (U.S.) · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. No email attachments. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (52)

Barnet Dulaney Perkins Eye Center	Mesa, Arizona, United States	Recruiting
California Retina Consultants	Bakersfield, California, United States	Completed
Retina Associates of Southern California	Huntington Beach, California, United States	Recruiting
California Eye Specialists Medical group Inc.	Pasadena, California, United States	Completed
Retinal Consultants Med Group	Sacramento, California, United States	Recruiting
University of California San Francisco	San Francisco, California, United States	Recruiting
Orange County Retina Med Group	Santa Ana, California, United States	Recruiting
Macula Retina Vitreous Research Institute	Torrance, California, United States	Recruiting
Southwest Retina Consultants	Durango, Colorado, United States	Completed
Advanced Vision Research Institute	Longmont, Colorado, United States	Recruiting
Retina Group of New England	Waterford, Connecticut, United States	Withdrawn
Retina Specialty Institute	Pensacola, Florida, United States	Recruiting

+ 40 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04853251